Biodegradable drug-eluting stents: promises and pitfalls.
Di Mario
Carlo
C
Royal Brompton Hospital, Imperial College, London SW3 6NP, UK. c.dimario@rbht.nhs.uk
Ferrante
Giuseppe
G
D020341:Absorbable Implants / Q000009:adverse effects*; D003328:Coronary Thrombosis / Q000209:etiology*; D016503:Drug Delivery Systems; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D000068338:Everolimus; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus